Healthcare is one of the fast¬est growing sectors in India and it is relatively offering a lower priced treatment options that provide a great opportunity for the growth of various segments across the industry – medical devices, pharmaceutical manuf
As of today, around 70 percent of critical Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) are imported. The PLlscheme is meant for promotion of domestic manufacturing of critical KSMs, Drug intermediates and APIs in India
The last year has been a whirl¬wind for the entire world, courtesy of the COVID-19 pan¬demic. With markets plummeting, businesses shutting down and indi¬viduals scampering to keep them¬selves safe, there has been a drastic change in industries
I ndia sees more than a million cases of cancer every year. While, countless efforts are being made all over the world to find a cure for this life-threating disease, we believe Precision Oncology can be the game changer in this direction.
A ttributing to increase in changing lifestyle, people of¬ten miss out on taking care of their health as a result of which there is an exponential increase of non-communicable diseases among the middle-aged population in the last decade.
Over 100 workers at a Mehta Pharmaceuticals facility in Chheharta that produced active pharmaceutical ingredients (API) from natural extracts and was recently shutdown has lost their jobs. There is currently just one API manufacturing unit left in...
AstraZeneca's antibody cocktail for preventing COVID-19, Evusheld, has now been recommended for treating the disease in the European Union , the company said on Friday, potentially broadening the market for a key therapy...
Mankind Pharma Limited has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI)...
The pharmaceuticals industry & life sciences industry when compared to various other industries is usually advanced in their application of technology. But when it comes to operations, the pharma sector has been cautious in adopting new technologies.
Glenmark Pharmaceuticals is banking on global rollout of specialty respiratory drug Ryaltris, making its US-based innovation unit Ichnos self-sustaining through more licensing deals, and expansion of branded formulation business in India, to help...
, CDSCO.jpg)
